Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer (Q82763120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

title

Clinical significance of IGF1R expression in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

19 December 2024

1 reference

2

Hidetaka Uramoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

8

Takeshi Hanagiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

9

Fumihiro Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

3

Soichi Oka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

4

Yasuhiro Chikaishi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

6

Hidehiko Shimokawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

5

Takashi Iwanami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Makoto Nakagawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

Tomoko So

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22133293

19 December 2024

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

full work available at URL

17 January 2020

https://api.elsevier.com/content/article/PII:S1525730411002488?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

https://api.elsevier.com/content/article/PII:S1525730411002488?httpAccept=text/plain

19 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

19 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

136-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

17 January 2020

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2008.19.9331

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-10-0089

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Time trends of surgical outcome in patients with non-small cell lung cancer

19 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study

19 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

19 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

19 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

TS expression predicts postoperative recurrence in adenocarcinoma of the lung

19 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis

19 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

19 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

The insulin-like growth factor system and cancer

19 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma

19 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Comment on ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’

19 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

A systems view of epithelial–mesenchymal transition signaling states

19 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Growth factors in induction of epithelial-mesenchymal transition and metastasis

19 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung

19 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

19 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer

19 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.

19 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC

19 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

19 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung

19 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status

19 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.

19 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)

19 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

19 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

19 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

19 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout

19 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

19 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials

19 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

IGF-1 receptor inhibitors in clinical trials--early lessons

19 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CLLC.2011.10.006

19 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22133293 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference